WASHINGTON, Dec 28 (Reuters) - The U.S. Federal Trade
Commission said on Wednesday that German pharmaceutical company
Boehringer Ingelheim agreed to divest five types of animal
health products to settle FTC charges that a proposed asset swap
with Sanofi would harm competition.
Read more
No comments:
Post a Comment